Supplements for Protection against Age-related Macular Degeneration

Supplements for Protection against Age-related Macular Degeneratio

New findings may help improve nutritional supplements for treating age-related macular degeneration (AMD), the leading cause of blindness nationwide.

AMD gradually destroys sharp, central vision as a person ages. The disease affects the macula, a region of the retina responsible for central vision. We rely on the macula for tasks that require sharp vision, such as reading, driving and recognizing faces. Some kinds of AMD are treatable if detected early, but no cure exists. About 2 million Americans have advanced AMD.

The Age-Related Eye Disease Study (AREDS), which was led by NIH’s National Eye Institute (NEI) and concluded in 2001, found that daily high doses of vitamins C and E, beta-carotene, and the minerals zinc and copper can help slow the progression to advanced AMD. However, beta-carotene use has been linked to lung cancer in smokers. The high zinc dose in the AREDS formulation may also cause minor side effects, such as stomach upset, in some people.

In 2006, NEI launched AREDS2 to test whether the AREDS formulation could be improved by adding omega-3 fatty acids; adding lutein and zeaxanthin; removing beta-carotene; or reducing zinc. Omega-3 fatty acids are produced by plants, including algae, and are found in oily fish such as salmon. Lutein and zeaxanthin are carotenoids, a class of plant-derived vitamins that includes beta-carotene. Past studies suggested that diets high in lutein, zeaxanthin, and omega-3 fatty acids protect vision. Before the AREDS2 study finished, manufacturers began including them in supplements.


 Get The Latest By Email

Weekly Magazine Daily Inspiration

The investigators enrolled more than 4,000 people between 50 and 85 years old who were at risk for advanced AMD. Participants were assigned to take 1 of 4 formulations daily for 5 years: the original AREDS, AREDS with no beta-carotene, AREDS with low zinc, or AREDS with no beta-carotene and low zinc. Participants in each group also took 1 of 4 supplements or combinations: lutein/zeaxanthin, omega-3 fatty acids, lutein/zeaxanthin and omega-3 fatty acids, or an inactive placebo.

Adding omega-3 fatty acids or lowering zinc had no effect on AMD progression. However, the investigators did find some benefits in the lutein/zeaxanthin mixture for those not given beta-carotene and those who had very little lutein and zeaxanthin in their diets. The lutein/zeaxanthin mixture was also safer than beta-carotene for smokers.

Man reading the label on a vitamin bottle.We have identified a formulation that should be good for everyone regardless of smoking status,” says co-author Dr. Wai T. Wong of NEI.

AREDS2 investigators also reported on the effects of these formulas on cataract, a clouding of the eye’s lens that is common in older people. Like the original AREDS formulation, none of the modified treatments had a significant effect on progression to cataract surgery. However, participants with low dietary lutein and zeaxanthin did seem to gain some protection.

Many factors contribute to the development of AMD and cataract, including genetics, diet and smoking. While scientists are still unsure how supplements in the AREDS formulation exert their protective effects, these results will aid efforts to prevent vision loss from AMD.

  • http://www. nih. gov/researchmatters/march2013/03112013macular.
  • http://www. nih. gov/researchmatters/april2010/04192010eye.
  • http://www. nih. gov/researchmatters/may2012/05072012vision.
  • http://www. nei. nih. gov/health/maculardegen/index.
  • http://www. nei. nih.


2013 May 5:1-11. doi: 10. 1001/jama. 2013. 4997. Epub ahead of print]. PMID: 23644932.

2013 May 5:1-7. doi: 10. 1001/jamaophthalmol. 2013. 4412. Epub ahead of print]. PMID: 23645227.

NIH’s National Eye Institute (NEI), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA), National Heart, Lung and Blood Institute (NHLBI), National Center for Complementary and Alternative Medicine (NCCAM) and Office of Dietary Supplements (ODS).

Article Source: NIH Research Matters

AVAILABLE LANGUAGES

English Afrikaans Arabic Chinese (Simplified) Chinese (Traditional) Danish Dutch Filipino Finnish French German Greek Hebrew Hindi Hungarian Indonesian Italian Japanese Korean Malay Norwegian Persian Polish Portuguese Romanian Russian Spanish Swahili Swedish Thai Turkish Ukrainian Urdu Vietnamese

follow InnerSelf on

facebook icontwitter iconyoutube iconinstagram iconpintrest iconrss icon

 Get The Latest By Email

Weekly Magazine Daily Inspiration

Wednesday, 05 May 2021 08:15

While our immune system and antibiotics both do a great job of helping us fight life-threatening infections, the emergence of antibiotic resistance is quickly making it more difficult to cure...

Sunday, 23 May 2021 08:15

We sometimes need to use antibiotics to treat sick animals, but taking advantage of opportunities to reduce antibiotics use could benefit everyone

Tuesday, 18 May 2021 16:15

In my blog posts, free resources, and courses, I talk a lot about the things that we can do to support and develop our inborn, natural interspecies communication abilities. In this post, I...

Friday, 02 April 2021 08:02

  Microdosing has become something of a wellness trend in recent years. The practice involves taking a low dose of a psychedelic drug to enhance performance, or reduce stress and anxiety.

Friday, 14 May 2021 08:30

Fertility has declined in most industrialised countries. While the causes are largely unknown, a number of factors may contribute to declining fertility rates, including the age...

Monday, 07 June 2021 08:07

Injury to the adult brain is all too common. A brain injury will often show up on brain scans as a well-defined area of damage. But often the changes to the brain extend far beyond the visible...

New Attitudes - New Possibilities

InnerSelf.comClimateImpactNews.com | InnerPower.net
MightyNatural.com | WholisticPolitics.com | InnerSelf Market
Copyright ©1985 - 2021 InnerSelf Publications. All Rights Reserved.